Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Major Malformations: The Importance of Serotonin for Embryonic Development and the Effect of Serotonin Inhibition on the Occurrence of Malformations-Reference-Cited by-同舟云学术

Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Major Malformations: The Importance of Serotonin for Embryonic Development and the Effect of Serotonin Inhibition on the Occurrence of Malformations

Published:2019-03 Issue:1 Volume:1 Page:18-29
ISSN:2576-3105
Container-title:Bioelectricity
language:en
Short-container-title:Bioelectricity

Author:

Bérard Anick¹,Levin Michael²,Sadler Thomas³,Healy David⁴

Affiliation:

1. Faculty of Pharmacy, University of Montreal; Research Center, CHU Sainte-Justine, Montreal, Quebec, Canada.

2. Allen Discovery Center at Tufts University, Department of Biology, Medford, Massachusetts.

3. Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City, Utah.

4. Department of Psychiatry, Hergest Unit, Bangor, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Transplantation,Electrical and Electronic Engineering,Biomedical Engineering,Medicine (miscellaneous)

Link

https://www.liebertpub.com/doi/pdf/10.1089/bioe.2018.0003

Reference184 articles.

1. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort

2. Use of antidepressants during pregnancy and the risk of spontaneous abortion

3. Rates of Spontaneous and Therapeutic Abortions Following Use of Antidepressants in Pregnancy: Results From a Large Prospective Database

4. Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concomitant use of antidepressants and benzodiazepines during pregnancy and associated risk of congenital malformations: a population-based cohort study in Taiwan;The Lancet Psychiatry;2024-08

2. Association of Commonly Prescribed Antepartum Medications and Incidence of Orofacial Clefting;The Cleft Palate Craniofacial Journal;2024-03-06

3. Drug-induced fetal and offspring disorders, beyond birth defects;Therapies;2023-11

4. Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997–2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014–2018);Pharmacoepidemiology and Drug Safety;2023-03-29

5. The nature of the binding between insulin receptor and serotonin transporter in placenta (review);Placenta;2023-03